Skip to main content
. 2023 Sep 29;27:376. doi: 10.1186/s13054-023-04654-9

Table 1.

Characteristics of the cohort of one-year sepsis survivors

Men N = 10 556 Women N = 7994
Admission year, N (%)
2005–2008 2074 (19.6) 1557 (19.5)
2009–2012 3721 (35.3) 2773 (34.7)
2013–2016 4761 (45.1) 3664 (45.8)
Age at sepsis diagnosis, median (IQR) 67 (56–75) 65 (52–74)
Charlson comorbidity index, N (%)
0 9 021 (85.5) 7 276 (91.0)
1–2 669 (6.3) 355 (4.4)
3 or more 849 (8) 344 (4.3)
Data missing 17 (0.2) 19 (0.2)
AIDS, N (%)
Yes 11 (0.1) 6 (0.1)
No 8319 (78.8) 6350 (79.4)
Data missing 2226 (21.1) 1638 (20.5)
Cirrhosis, N (%)
Yes 112 (1.1) 86 (1.1)
No 8218 (77.9) 6270 (78.4)
Data missing 2226 (21.1) 1638 (20.5)
Admission type
Surgical admission, N (%) 1523 (14.4) 1304 (16.3)
Elective, N (%) 281 (18.5) 193 (14.8)
Emergency, N (%) 1242 (81.5) 1111 (85.2)
Data missing 53 (0.5) 19 (0.24)
Emergency admission, N (%)
Yes 10,041 (95.5) 7683 (96.1)
No 477 (4.2) 298 (3.7)
Data missing 38 (0.3) 13 (0.2)
SAPS 3, median (IQR) 62 (54–71) 60 (52–69)
Vasoactive treatment on admission, No (%)
Yes 1330 (12.6) 1030 (12.9)
No 7000 (66.3) 5326 (66.6)
Data missing 2223 (21.1) 1638 (20.5)
ICU length of stay, N (%)
 < 1 d 4446 (42.1) 3336 (41.7)
1–2 d 2077 (19.7) 1740 (21.8)
3–7 d 1025 (9.7) 741 (9.3)
8–14 d 391 (3.7) 273 (3.4)
 > 14 d 391 (3.7) 266 (3.3)
Data missing 2223 (21.1) 1638 (20.5)
Cancer diagnosis within 5 years before onset of follow-up*, N (%)
Yes 2324 (22) 1384 (17.3)
No 8232 (78) 6610 (82.7)
Ongoing cancer treatment on admission, N (%)
Yes 657 (6.2) 590 (7.4)
No 7673 (72.7) 5766 (72.1)
Data missing 2226 (21.1) 1638 (20.5)

Characteristics of the cohort of one-year sepsis survivors at the index ICU admission or at the start of follow-up (i.e., one year after the index admission). IQR inter-quartile range, SAPS 3 Simplified Acute Physiology Score 3, AIDS acquired immune deficiency syndrome

*Based on data from Swedish Cancer Registry